- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07692919
VIA Versus Colposcopy
Visual Inspection With Acetic Acid of The Cervix Versus Colposcopy in Screening and Detection of Cervical Intraepithelial Neoplasia
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Method of study:
Medical and surgical history of the patients will be taken, clinical examinations of the patients will be performed and routine laboratory investigations will be done.
Patients will be asked to empty their bladder and positioned in the lithotomy or dorsal supine position on the examination table. Standard infection control measures will be followed, including hand hygiene and use of sterile gloves and speculum.
Visual Inspection with Acetic Acid (VIA) VIA will be conducted by trained gynecology residents under consultant supervision. A 5% acetic acid solution will be applied to the cervix, and after one minute, the cervix will be inspected under adequate light. The appearance of acetowhite areas will be considered VIA positive, indicating possible precancerous changes.
Colposcopy Women who are candidate for colposcopy assessment or with abnormal Pap smear will be referred for colposcopic evaluation using a binocular colposcope (magnification: 5×, 10×, and 20×) with a green filter to assess vascular patterns.
Lesions will be scored using the Swede score, an open access validated colposcopic scoring system based on five criteria: uptake of acetic acid, margins and surface, vessels, lesion size, and iodine staining Scores 0-4: normal or low-grade lesion (CIN 1 or less) Scores 5-6: possible high-grade lesion (CIN 2) Scores 7-10: high-grade lesion/CIN 3 or invasive cancer (11). Biopsy and Histopathology Colposcopy-guided biopsies will be performed only in patients with a Swede score ≥ 5, following standard protocols to avoid unnecessary invasive procedures in low-grade lesions. Biopsy specimens will be fixed in 10% formalin, processed, stained with hematoxylin and eosin, and examined under light microscopy.
Histopathological findings will be classified as:
Chronic cervicitis CIN 1, CIN 2, CIN 3 Carcinoma in situ Squamous cell carcinoma (SCC) Adenocarcinoma Classification followed WHO standards (12).
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: bassam mahmoud abdallah Mahmoud Abdallah, resident
- Telefonnummer: +201012200274
- E-mail: bmmcamille@gmail.com
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Age from 25 to 65 years.
- Patient undergoing cervical cancer screening using VIA and colposcopy.
- Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding.
- Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization)
- Women with Pap smear showing dysplasia.
Exclusion Criteria:
• Pregnant women (if VIA or colposcopy is contraindicated).
- Women with obvious invasive cervical cancer diagnosed previously.
- Women who refuse to provide informed consent or are unable to cooperate with the examination.
- Women having active vaginal bleeding.
- Any past treatment for cervical lesions.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
VIA Versus Colposcopy in terms of in terms of sensitivity and specificity
Tidsramme: 2 weeks
|
Patients will be observed for any immediate discomfort or minor complications such as spotting, mild cramping, or vaginal irritation following VIA, colposcopy, or biopsy. All patients will be advised on post-procedure care, including avoiding vaginal do |
2 weeks
|
|
sensitivity and specificity in diagnosis of pre-malignant cervical lesions among women
Tidsramme: From enrollment to the the result at 14 days
|
Patients will be observed for any immediate discomfort or minor complications such as spotting, mild cramping, or vaginal irritation following VIA, colposcopy, or biopsy. All patients will be advised on post-procedure care, including avoiding vaginal douching, sexual activity, or use of tampons for a few days, if a biopsy will be performed. Results of the VIA, colposcopy, and histopathology will be explained to the patients, and appropriate follow-up or referral will be arranged for those with CIN 2, CIN 3, or carcinoma. Patients will be instructed to report any unusual bleeding, pain, or discharge immediately to the clinic. |
From enrollment to the the result at 14 days
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Soh-Med-26-6-23MS
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Cervicitis
-
Tanta UniversityAfsluttetKræft i livmoderhalsen | CIN | CervicitisEgypten
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
Massachusetts General HospitalAmerican Sexually Transmitted Diseases AssociationAfsluttetSeksuelt overførte infektioner | Cervicitis | UrethritisForenede Stater
-
Ostergotland County Council, SwedenStatens Serum InstitutUkendtChlamydia Trachomatis | Cervicitis | Urethritis | Genital Mycoplasma InfektionSverige
Kliniske forsøg med VIA
-
Eli Lilly and CompanyRekruttering
-
Helsinki University Central HospitalUniversity of HelsinkiAfsluttetPancreassygdomme | BugspytkirtelkræftFinland
-
University of California, BerkeleyAfsluttetFysisk aktivitet | Stillesiddende livsstilForenede Stater
-
Madrigal Pharmaceuticals, Inc.AfsluttetLægemiddelsikkerhedForenede Stater
-
Istanbul UniversityAfsluttetSklerodermi, systemisk | Rehabilitering | Fysioterapi | Sklerodermi | Håndgigt | Scleroderma Associated Digital UlcusKalkun
-
VA Office of Research and DevelopmentAfsluttetMultimorbiditet | Kognitive svækkelserForenede Stater
-
University of California, Los AngelesUCLA Health Department of MedicineAfsluttetDiabetes | Kræft | SundhedsvedligeholdelseForenede Stater
-
Marmara UniversityIkke rekrutterer endnu
-
University of Electronic Science and Technology...Afsluttet